Subtype
Malignant Neoplasm of Unknown Primary
CI-CAN-00001150CUPExplore in graph →
4,163 active trials54 approved drugs532 evidence items
- NCIt
- C8566
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001150CUPExplore in graph →
Clinical trials
14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,895)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00083889 | SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 750 | PfizerINDUSTRY | 11 | Jan 26, 2010 | clinicaltrials |
| NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | unknown | Phase 2 | 250 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 26, 2010 | clinicaltrials |
| NCT00947102 | Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer(GEMSTHER) | unknown | — | — | Blood Transfusion Centre of SloveniaOTHER_GOV | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00089648 | SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 61 | PfizerINDUSTRY | 1 | Jan 12, 2010 | clinicaltrials |
| NCT00351949 | IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC) | completed | Phase 1 | 24 | Immutep S.A.S.INDUSTRY | 1 | Jan 7, 2010 | clinicaltrials |
| NCT01041482 | A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma(AGuo) | unknown | Phase 2 | 140 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00392366 | Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis | completed | N/A | 25 | BioTex, Inc.INDUSTRY | 1 | Jan 1, 2010 | clinicaltrials |
| NCT00858000 | Analysis of Expression of Specific Markers in Hepatocellular Carcinoma | completed | — | 30 | GlaxoSmithKlineINDUSTRY | 1 | Dec 24, 2009 | clinicaltrials |
| NCT00869011 | Exercise for Patients With Renal Cell Cancer Receiving Sunitinib | unknown | Phase 3 | 70 | Charite University, Berlin, GermanyOTHER | 1 | Dec 23, 2009 | clinicaltrials |
| NCT01033578 | Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis | unknown | N/A | 260 | Fudan UniversityOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00140478 | Mifepristone (RU-486) in Androgen Independent Prostate Cancer | completed | Phase 2 | 48 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00006361 | SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 4, 2009 | clinicaltrials |
| NCT01018381 | Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | completed | N/A | 130 | The 108 Military Central HospitalOTHER_GOV | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00494026 | Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) | terminated | Phase 2 | 4 | Eli Lilly and CompanyINDUSTRY | 4 | Nov 20, 2009 | clinicaltrials |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 908 | Eli Lilly and CompanyINDUSTRY | 26 | Oct 28, 2009 | clinicaltrials |
| NCT00447421 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | terminated | Phase 1 / Phase 2 | 9 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 28, 2009 | clinicaltrials |
| NCT00999843 | Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer | unknown | Phase 1 / Phase 2 | 30 | Fudan UniversityOTHER | 1 | Oct 22, 2009 | clinicaltrials |
| NCT00960167 | A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) | unknown | Phase 1 | 20 | National Taiwan University HospitalOTHER | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00868725 | Detecting Lesions in the Oral Cavity With Thermal Imaging | completed | — | 50 | Sheba Medical CenterOTHER_GOV | 1 | Oct 1, 2009 | clinicaltrials |
| NCT00319969 | Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. | completed | Phase 2 | 76 | Celgene CorporationINDUSTRY | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00740441 | A Phase II Study of AS1411 in Renal Cell Carcinoma | unknown | Phase 2 | 30 | Antisoma ResearchINDUSTRY | 1 | Sep 25, 2009 | clinicaltrials |
| NCT00280618 | Oxaliplatin in Unresectable Hepatocellular Carcinoma | completed | Phase 2 | — | SanofiINDUSTRY | 0 | Sep 15, 2009 | clinicaltrials |
| NCT00630240 | Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization | completed | — | 53 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 1, 2009 | clinicaltrials |
| NCT00625768 | Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | completed | Phase 1 | 13 | Antisoma ResearchINDUSTRY | 2 | Aug 25, 2009 | clinicaltrials |
| NCT00495846 | GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma(SS-HCC) | completed | Phase 2 / Phase 3 | 25 | Federico II UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00960518 | TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)(TACE) | unknown | Phase 2 | 216 | Tongji UniversityOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 52 | Massachusetts General HospitalOTHER | 0 | Aug 10, 2009 | clinicaltrials |
| NCT00953394 | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | completed | Phase 2 | 29 | University of Turin, ItalyOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00769730 | Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication | completed | — | 25 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00945984 | Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma(LESS) | unknown | — | 36 | Seoul National University HospitalOTHER | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00945568 | Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life(KMS) | completed | N/A | 100 | Kochi UniversityOTHER | 1 | Jul 24, 2009 | clinicaltrials |
| NCT00495924 | Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma | completed | — | 100 | KU LeuvenOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00464919 | Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Taiwan University HospitalOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00644254 | The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma(ECLNI DPAC) | completed | — | 145 | KU LeuvenOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00390195 | Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 134 | National Health Research Institutes, TaiwanOTHER | 1 | Jul 2, 2009 | clinicaltrials |
| NCT00522639 | Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation(FDG-PET lung) | terminated | Phase 3 | 120 | Maastricht Radiation OncologyOTHER | 1 | Jun 30, 2009 | clinicaltrials |
| NCT00572923 | Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans(BRONC 45 15) | completed | — | 52 | Maastricht Radiation OncologyOTHER | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00475657 | Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer | terminated | Phase 2 | 5 | Eli Lilly and CompanyINDUSTRY | 1 | May 29, 2009 | clinicaltrials |
| NCT00389285 | Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 52 | ZymoGeneticsINDUSTRY | 1 | May 27, 2009 | clinicaltrials |
| NCT00259987 | Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus | completed | Phase 2 | 24 | GlaxoSmithKlineINDUSTRY | 3 | May 18, 2009 | clinicaltrials |
| NCT00902902 | A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark | unknown | — | 0 | Peking Union Medical College HospitalOTHER | 1 | May 15, 2009 | clinicaltrials |
| NCT00591188 | Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens | completed | Phase 2 | 49 | Kidney Cancer Research BureauOTHER | 1 | May 1, 2009 | clinicaltrials |
| NCT00435578 | Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma | terminated | Phase 2 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00102700 | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | completed | Phase 2 | 66 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00890110 | Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib(rcc) | unknown | Phase 1 / Phase 2 | 13 | Hadassah Medical OrganizationOTHER | 0 | Apr 29, 2009 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165230 | Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00358930 | A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 60 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00255476 | The IRESSA Novel Head and Neck Chemotherapy Evaluation Study | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Jan 26, 2010source: clinicaltrials